The effect of saffron on lipid ,FBG and depression and anxiety in patients with metabolic syndrome

Investigation the effect of Crocin saffron on four index include lipid profile ,FBG and depression and anxiety in patients with metabolic syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160308026961N4

Enrollment

166

Registered

2018-03-26

Start date

2018-03-11

Completion date

Unknown

Last updated

2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome. Nutritional and metabolic disorders in diseases classified elsewhere

Interventions

Intervention 1: The intervention group will receive daily 30 mg of crocin in the form of two 15 mg tablets for 8 weeks. Intervention 2: The control group will receive daily 30 mg of placebo in the for

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: People with BMI = 303 No pregnancy and lactation History of heart disease History of fat-related diseases, and mellitus diabetes The history of taking any type of lipid-lowering drug

Exclusion criteria

Exclusion criteria: History of systemic disease (lupus)

Design outcomes

Primary

Measure	Time frame
Blood fat. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on blood tests.;Depression. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on Beck depression inventory (BDI).;Anxiety. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on Beck depression inventory (BDI).	—

Measure

Time frame

Blood fat. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on blood tests.;Depression. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on Beck depression inventory (BDI).;Anxiety. Timepoint: At the beginning and end of the study (eight weeks after the start of the study). Method of measurement: Based on Beck depression inventory (BDI).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahla Amini

Emam Reza Hospital

sh.amini93@yahoo.com+98 83 3427 6301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026